Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...

RnD® platform connects targets, compounds and authenticated human cell models to reduce manual searching and enable ...

AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...

A study introduces a scalable 2D human neuron platform to probe how brain-like rhythms emerge and how specific drugs reshape them, aiding epilepsy and autism research.

According to data shared during SLAS, the platform was instrumental in helping BellBrook Labs identify 13 novel inhibitors of the protein.

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...

However, traditional calorimetric methods typically rely on single-channel measurements, complex fabrication, or long ...

Cells constantly monitor and recycle their proteins through a tightly regulated waste-disposal system. Proteins that are no ...

Enamine's Target-Agnostic Expertise in Biology, Drug Design, and Medicinal Chemistry Advances EMUNO Therapeutics ...

About Advanced Biomed Inc. Advanced Biomed Inc. is a Nevada corporation specializing in innovative biomedical technologies for cancer detection and precision medicine.

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.